PsiOxus Therapeutics Ltd develops novel therapeutics for serious diseases. We are an Oxford, London and Berlin based development stage biotechnology company with world leading scientists and a highly experienced management team. Our approach is to combine different elements including small molecules, viruses, polymers and other macro-molecules to produce novel patent protected therapeutics. We deliberately target diseases that result in significant associated global morbidity and mortality, with a particular focus upon cancer.